Endocrine, Metabolic & Immune Disorders - Drug Targets

(Formerly 'Current Drug Targets - Immune, Endocrine & Metabolic Disorders')

ISSN: 1871-5303 - Volume 8, 4 Issues, 2008

Co-Editors-in-Chief:

Emilio Jirillo
Universitá degli Studi di Bari
Dipartimento di Clinica Medica
Immunologia e Malattie Infettive
Sezione di Microbiologia e Immunologia
Piazza Giulio Cesare-Policlinico, Bari
Italy

Michael J. Quon
Chief, Diabetes Unit
NCCAM, NIH
9 Memorial Drive
Building 9, Room 1N105
Bethesda, MD 20892
USA

Associate Editors:

S.L. Berga (Emory University School of Medicine, Atlanta, GA, USA)
D. Caccavo (Immunologia - Policlinico, Bari, Italy)
A.M. DePaoli (Thousand Oaks, CA, USA)
P.P. Di Fiore (FIRC Institute of Molecular Oncology, Milan, Italy)
M.A. Freudenberg (Max-Planck-Inst. fuer Immun., Freiburg, Germany)
C. Galanos (Max-Planck-Institut fuer Immunbiologie, Freiburg, Germany)
M.L. Reitman (Merck & Co, Inc., Rahway, NJ, USA)
P.M. Yen (The Johns Hopkins Bayview Med. Ctr., Baltimore, MD, USA)

Editorial Advisory Board:

C.R. Alving (Walter Reed Army Inst. of Res., Silver Spring, MD, USA)
A.D. Baron (Amylin Pharmaceuticals, Inc., San Diego, CA, USA)
J.B. Bartlett (Celgene Corporation, Summit, NJ, USA)
N.H. Bell (Med. Univ. of South Carolina, Charleston, SC, USA)
Z. Benttwich (Rosetta Genomics Science Park, Rehovot, Israel)
J.W.J. Bijlsma (Univ. of Med. Ctr. Utrecht, Utrecht, The Netherlands)
F. Buttgereit (Universitaetsmedizing charite, Berlin, Germany)
U. Chattopadhyay (Chittaranjan Nat. Cancer Institute, Culcutta, India)
G.P. Chrousos (NICHHD, NIH, Bethesda, USA)
I.R. Cohen (Weizmann Institute of Science, Rehovot, Israel)
G. Corradin (University of Lausanne, Epalinges, Switzerland)
G. Dighiero (Institut Pasteur, Paris, France)
B. Draznin (Denver VA Medical Center, Denver, CO, USA)
J.C.W. Edwards (Centre for Rheumatology, London, UK)
B.J. Goldstein (Thomas Jefferson University, Philadelphia, PA, USA)
B.A 't Hart (Biomed. Primate Res. Centre, Rijswijk, The Netherlands)
E. Karnieli (Rambam Medical Center, Haifa, Israel)
A.S. Lalani (Regeneron Pharmaceuticals, Westchester, NY, USA)
F. Liu (UTHSCSA, San Antonio, TX, USA)
H.D. Mason (St. George's University of London, London, UK)
I.B. Mclnnes (University of Glasgow, Glasgow, UK)
J. Miyan (Univ. of Manchester Inst. of Sci. & Tech., Manchester, UK)
J. O'Connell (National University of Ireland, Cork, Ireland)
L. O'Neill (Trinity College Dublin, Dublin, Ireland)
N.M. Pellegrino (Immunologia - Policlinico, Bari, Italy)
R. Rappuoli (RIS, Chiron SpA, Siena, Italy)
D. Le Roith (NIH, Bethesda, MD, USA)
R. Salomao (Universidade Federal de Sao Paulo, Sao Paulo, Brazil)
N.J. Sarlis (Univ. of Texas, Houston, TX, USA)
B.-H. Toh (Monash University Medical School, Prahran, Victoria, Australia)
J.A. Trapani (Peter MacCallum Cancer Inst., East Melbourne, Australia)
N.A. Williams (University of Bristol, Bristol, UK)